Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M156Revenue (TTM) $M49.6Net Margin (%)-43.4Altman Z-Score0.6
Enterprise Value $M114EPS (TTM) $-0.1Operating Margin %-43.2Piotroski F-Score6
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)-43.0Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %-0.5Quick Ratio2.7Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %28.7Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-26.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-34.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M155ROIC % (ttm)-108.8Gross Margin Increase y-yY

Gurus Latest Trades with ATRS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ATRSFirst Eagle Investment 2012-06-30 Sold Out $2.72 - $3.71
($3.13)
$ 1.01-68%Sold Out0
ATRSFirst Eagle Investment 2010-06-30 Buy $1.48 - $1.95
($1.66)
$ 1.01-39%New holding20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ATRS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ATRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GRAHAM PETER JSVP General Counsel, Secretary 2016-03-21Buy20,000$0.7731.17view
APPLE ROBERT FPresident & CEO 2016-03-18Buy60,000$0.7240.28view
GUETH ANTONDirector 2016-03-18Buy50,000$0.7240.28view
Fickenscher James ESenior Vice President & CFO 2016-03-18Buy135,000$0.7240.28view
JACOB LEONARD SDirector 2016-03-18Buy50,000$0.7240.28view
GONELLA JACQUESDirector 2016-03-18Buy100,000$0.7240.28view
GARRITY THOMAS JDirector 2016-03-18Buy30,000$0.7240.28view
SAMSON MARVINDirector 2016-03-18Buy50,000$0.7240.28view
ROCHE ROBERT P JRDirector 2016-03-18Buy50,000$0.7240.28view
Flynn James E 2015-09-30Sell1,828,529$1.79-43.58view

Quarterly/Annual Reports about ATRS:

News about ATRS:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016 
Weekly CFO Sells Highlight: ATRS, DENN, TTWO, JAH, ACET Jun 11 2013 

More From Other Websites
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 01 2016
Antares Pharma (ATRS) in Focus: Stock Moves 10.2% Higher Jun 28 2016
TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States Jun 27 2016
Teva and Antares Pharma Announce Launch of Generic Imitrex® in the United States Jun 27 2016
Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product Jun 23 2016
Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product Jun 23 2016
ETF’s with exposure to Antares Pharma, Inc. : June 20, 2016 Jun 20 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Other Events Jun 16 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 08 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 07 2016
ETF’s with exposure to Antares Pharma, Inc. : June 3, 2016 Jun 03 2016
Antares Pharma to Present at the Jefferies 2016 Healthcare Conference Jun 01 2016
Antares Pharma Announces Update to Quickshot Testosterone Program Jun 01 2016
Antares Pharma Announces Update to QuickShot Testosterone Clinical Program Jun 01 2016
ETF’s with exposure to Antares Pharma, Inc. : May 19, 2016 May 19 2016
Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
ANTARES PHARMA, INC. Financials May 17 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 09 2016
Antares Pharma Reports First Quarter 2016 Financial and Operating Results May 09 2016
Antares Pharma reports 1Q loss May 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)